加强非洲大陆的疫苗能力建设。
Strengthening vaccine capacity building on the African continent.
出版信息
Nat Commun. 2025 Aug 13;16(1):7525. doi: 10.1038/s41467-025-62839-y.
Abstract
The African Union (AU) has set an ambitious goal to strengthen primary health care systems on the African continent and achieve universal health coverage for all African citizens by 2030. As part of this initiative, the AU advocates for African self-reliance in the manufacturing of life-saving vaccines and drugs. Here, we speak with Professor Nicaise Ndembi and Dr Jerome Kim, who are at the forefront of capacity building for African vaccine manufacturing, about the progress that has been made towards the AU’s goal, and what challenges remain.
摘要
非洲联盟（非盟）设定了一个雄心勃勃的目标，即加强非洲大陆的初级卫生保健系统，并在2030年前为所有非洲公民实现全民健康覆盖。作为该倡议的一部分，非盟倡导非洲在生产救命疫苗和药品方面实现自力更生。在此，我们采访了处于非洲疫苗生产能力建设前沿的尼凯斯·恩登比教授和杰罗姆·金博士，了解在实现非盟目标方面取得的进展以及仍然存在的挑战。
相似文献
1
Strengthening vaccine capacity building on the African continent.
Nat Commun. 2025 Aug 13;16(1):7525. doi: 10.1038/s41467-025-62839-y.
2
Contribution of polio eradication initiative to strengthening routine immunization: Lessons learnt in the WHO African region.
Vaccine. 2016 Oct 10;34(43):5187-5192. doi: 10.1016/j.vaccine.2016.05.062. Epub 2016 Jul 7.
3
African-led health research and capacity building- is it working?
BMC Public Health. 2020 Jul 14;20(1):1104. doi: 10.1186/s12889-020-08875-3.
4
Approaches and impact of non-academic research capacity strengthening training models in sub-Saharan Africa: a systematic review.
Health Res Policy Syst. 2015 Jun 9;13:30. doi: 10.1186/s12961-015-0017-8.
5
A capacity strengthening model toward self-reliant and sustainable one-health workforce in six East African Community Partner States.
Front Public Health. 2025 Jul 24;13:1636817. doi: 10.3389/fpubh.2025.1636817. eCollection 2025.
6
Building global vaccine manufacturing capacity: Spotlight on Africa.
Vaccine. 2023 Jun 19;41(27):4050-4056. doi: 10.1016/j.vaccine.2023.05.009. Epub 2023 May 11.
7
Eliciting initial programme theories for a health research capacity strengthening initiative targeting African universities: A realist synthesis.
PLoS One. 2025 Aug 20;20(8):e0330360. doi: 10.1371/journal.pone.0330360. eCollection 2025.
8
A continent-wide effort and solidarity at curbing COVID-19 pandemic: the Africa task force for novel coronavirus (AFTCOR) infection prevention and control technical working group's experience.
BMC Public Health. 2023 May 15;23(1):893. doi: 10.1186/s12889-023-15706-8.
9
"We need more big trees as well as the grass roots": going beyond research capacity building to develop sustainable careers in mental health research in African countries.
Int J Ment Health Syst. 2020 Aug 14;14:66. doi: 10.1186/s13033-020-00388-1. eCollection 2020.
10
Strengthening Vaccine Safety Systems, Research, and Regional Collaboration in Africa: A Call to Action.
Vaccines (Basel). 2025 Jun 19;13(6):661. doi: 10.3390/vaccines13060661.
本文引用的文献
1
Bridging the vaccine divide.
Nat Med. 2025 Jun;31(6):1737. doi: 10.1038/s41591-025-03728-1.
2
Advancing local manufacturing capacities for vaccines within Africa - Opportunities, priorities and challenges.
Vaccine. 2025 Mar 19;50:126829. doi: 10.1016/j.vaccine.2025.126829. Epub 2025 Feb 5.
3
African leadership is critical in responding to public health threats.
Nat Commun. 2024 Jan 29;15(1):877. doi: 10.1038/s41467-024-45220-3.
4
Impact of serogroup A meningococcal conjugate vaccine for Africa.
Hum Vaccin Immunother. 2018 May 4;14(5):1116-1117. doi: 10.1080/21645515.2017.1412022. Epub 2018 Jan 16.
5
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.
Lancet Infect Dis. 2017 Aug;17(8):867-872. doi: 10.1016/S1473-3099(17)30301-8. Epub 2017 May 22.
6
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India.
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S483-8. doi: 10.1093/cid/civ500.
Zotero 插件